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Aetiology, diagnosis and therapy of thrombosis have been treated of in a
number of publications. There are, however, many unknown factors left
over in connection with the problem of the origin of this disease. Some
research workers suggest the influence of meteorlogic and cosmic circumstances
as its origin. Others (e.g. OCHSNER) stress the importance of smoking and trauma
and the vasospasmodic effects to be responsible. TROSSEAU and his collabo-
rators point out the part played by tuberculosis and cancer, BURK.E emphaszes
heredity and constitution as the determining factors. As a matter of fact, we
have no satis.£actory solution for this problem up to the present, in spite of both
research work and scientific observations being carried on with a persistent
endeavour adequate to the importance of the disease. Besides the simple methods
depending on the external symptoms of thrombosis (changes of temperature,
colour of the skin, etc.) we succeeded in clearing up the microscopic, physical
and colloid-chemical conditions of the coagulating process with the aid of more
sensitive apparatuses. We know about the fine structure of the blood-disks, their
disposition for pseudopody and coagulation. We also know that prothrombin,
thrombin and thrombokinase. are coagulating and anti-thrombin and antikinase
are inhibiting factors. We know that coagulating factors are combined with
globulin, that inhibitory factors are combined with albumins. We know that
heparin develops in the special cells+ of the reticula-endothelial system, not in
the hepatic cellules, etc.
Aetiological research has naturally led to the corresponding changes or
modifications of therapy. The discovery of the anticoagulants (heparin and di-
cumarol) marks a considerable progress in this field. Experiments had been
going on for a long time to make u~e of anticoagulants, such as hirudin, sodi-
um oxalate and sodium citrate. They did not, however, stand the test because
of the toxic symptoms caused when given in higher doses. The discovery of
heparin described by McLEAN in 1916 and put to use by CRADFORD was of
revolutionary importance. Then dicumarol was added to the list by LINK in
+ .. Ehrlichsche Mastzelle"
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1940, and this (with its derivatives) proved to be an effective though not a
harmless means for fighting thrombosis. In addition, RAPPERT was the first to
describe, in 1952, a treatment of thrombotic cases with hydergineqanthesis.
Besides these simple procedures the clinician is aided in establishing a dia-
gnosis or in controlling the ensuinganti coagulant treatment by the LoWENBERG
test as well as by the macro-and microhaematological examination methods of
QUICK (1), SoULIER (2), SZIRMAI (3, 4). SZIRMAI's examinatinations by means
of the myograph present a novelty in registering thrombophlebitis resp. throm-
bosis in the lower extremities.
As it is well known, circulation in the extremities as a rule is not fully
arrested by the thrombi of the vessels, as the collateral tracks generally remain
active. The fact should not, however, be ignored that, in such cases, collateral
function also is disturbed by contraction occurring through reflex courses.
According to the grade of collateral capacity, symptoms may vary considerably.
In addition to the external symptoms of thrombosis (changes in temperature and
colour of the skin), the respective musculature generally feels slack as a result
of the decrease of blood supply in the motor nerves. Under certain circum-
stances musculature falls into a state of ataxic weakness and even a complete
motoric ataxy may occur. (7)
In cases of other diseases we 'have already been able to register with the
myograph changes in the values of contraction and tonus resulting from insuffici-
ent blood circulation.
Our actual examinations had the purpose to state whether, by means of
Szirmai's neomyograph (Fig. 7) an apparatus far more sensitive than the myo-
graph the results of our anticoagulating treatment could be registered, indepen-
dently from the subjective feelings of our patients, on the mere basis of the
changes in the tonus and contraction values of the muscles. Therefore, besides
physical examination methods, we observed prothrombin activity and'made a
myogram with each patient before starting the actual treatment. During the
anticoagulating treatment itself we have concentrated our attention on prothrom-
bin activity and have made another myogram when the cure was completed.
According to the respective prothrombin level of our patients, we started
the anticoagulating treatment with administering thromasal pills containing
phenylindandiona product of the Pharmaceutical Factory Asal+. The treatment
was continued by local and peroral administration of vasodilators until objective
and subjective symptoms disappeared.
Above examinations have been executed on 28 patients. Results are summed
up in Table 1.
+ We herewith wish to express our gratitude to the Pharmaceutical F~ctory Asal, Berlin,
for granting the use of Thromasal pills for our research purposes.
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Prothrombin- Neomyogram in
activity before Result ofName Diagosis and after myotons
treatment before and after therapy
96 treatment
H.T. Thrombosis cruris 1. sin. 127 66 1.5 11.0 good
K. S. Thrombophlebitis 1. sin. 109 74 2.0 10.0 good
K.K. Thrombosis cruris 1. d. 110 58 1.0 9.0 satisfactory
T.K. Thrombosis cruris 1. sin. 120 80 3.5 12.0 good
1. }. St. p. Thrombosis cruris 106 60 2.0 10.0 good
Gy.S. St. p. Thrombophlebitis 119 72 1.0 10.5 good
K.A. Thrombosis cruris 1. utr. 138 86 0.5 8.5 satisfactory
1. G. St. p. Thrombosis cruris 103 56 0.5 6.0 bad
A. T. Thrombophlebitis cruris 1. d. 108 70 2.0 13.0 good
B.P. St. p. Thrombosis cruris 1. sin 114 80 0.5 11.5 good
R.S. St. p. Thrombosis cruris 1. d. 107 74 1.5 10.5 good
L.A. Thrombosis cruris 1. d. 129 73 2.5 9.5 satisfactory
G.S. St. p. Thrombophlebitis 1. sin. 106 40 0.5 8.5 satisfactory
T.M. Thrombohlebitis cruris 1. d. 112 48 3.0 11.5 good
M.L. Thrombosis cruris 1. sin. 105 63 3.0 10.5 good
M.S. St. p. Thrombophlebitis 1. d. 109 68 2.0 7.5 bad
F.B. St. p. Thrombosis cruris 1. d. 119 60 1.5 10.5 good
Cs.S. Ulcus cruris 107 75 1.0 6.5 bad
D.T. Thrombosis cruris 112 66 1.5 9.6 satisfactory
B.H. Ulcus cruris 106 68 0.5 6.0 bad
N.}. Thrombosis cruris 109 55 1.5 7.0 bad
M.Cs. Thrombosis cruris 121 72 2.5 11.0 good
0.5. St. p. Thrombophlebitis 136 62 3.0 6.5 bad
S.}. Thrombosis cruris 103 54 2.5 10.0 good
Ty.A. Thrombosis st. p. partem 105 63 1.0 6.5 bad
V.T. Thrombosis cruris 102 48 1.5 6.0 bad
Sz.M. Thrombosis cruris 107 60 2.5 10.0 good
Gy.B. Thrombosis cruris 117 76 3.0 11.0 good
Table I. shows that, under a pressure of 30 myotons applied on our
patients before starting the treatment, the amplitudes of the myograms generally
give values of 1-2 myotons (1 myoton=lmm), 3 myotons rarely. Contrary
to these, in normal cases under similar conditions amplitudes of 10 to 12 myo-
tons are recorded. We may observe further, that as a result of the treatment,
control examinations present a rise in myogram values in 20 of the examined
cases, while in the remaining 8 cases postthrombotic syndromes and subjective
complaints were observed at repeated examinations.
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Our examinations have a double significance. They verify Szirmai's earlier
examinations (5, 8, 9) registering influence of decreased circulation on muscula-
ture. Furthermore, an exact record is compiled on the cure of our patients.
Summing up the above, we may state that neomyographic examinati00s
are along with the other mentioned methods very valuable in setting up diagno~
sis of thrombotic cases. The special advantage of the neomyograph shows in
enabling us after the complaints of the patients have ceased and when blood
coagulating factors are normalized to make exact measurements of the status of
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Fig. 2. Average percentage of prothrombin activity
in 28 cases examined.
53,4%
Fig. 4. Neomyogram, characteristic of a case of
thrombosis in both lower extremites. Passive (A) as
well as active (B) movements show equally small am-
Fig. 3. Therapeutical results based on plitudes. (To read from right to left)
changes in the myogram-values expres·
sed in percentages.
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Fig. 5. a. Neomyogram, characteristic of a case of
thrombosis in the right lower extremity (X2). The left limb
too shows a circulation worse than normal.
Fig. 5. b. After treatment in both limbs an essential improvement
is observed, strikingly shown by the myogram taken before and that
after the treatment.
Fig. 6. An a-year old thrombotic case with slight oedema in the left lower and a dis-
tinct one in the right lower limb resulting a restriction of the movement. This myogram shows
clearly that the active (B) movements of the left limb (XI) are severely confined, while the
values of the right limb (X2) are in the case of passive (A) as well as active (B) movements
about O.
the disease by registering tonus and contraction changes resulting from the im-
provement of circulation in the musculature.
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Fig. 7. Szirmai's Neomyograph
SUMMARY
Neomyographic examinations were made by the authors on 28 patients.
The extent of reconvalescence was measured on the basis of changes in the
values recorded by the myograms taken before and after the treatment.
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